Clinical Trials

Showing trials with last updates posted in 2026.

NCT07703436 | NOT_YET_RECRUITING | PHASE2
40 participants

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2027-03-31
Completion:
2030-09-30
Conditions
  • Grade 2 IDH1-mutant Glioma
  • Grade 3 IDH1-mutant Glioma
  • Glioma
  • IDH1-mutant Glioma
  • Oligodendroglioma
  • Oligodendroglioma IDH-1 Mutant and 1/p19q-codeleted
  • Astrocytoma IDH Mutant Grade 3
  • Astrocytoma IDH Mutant Grade 2
Interventions
  • DRUG
No Results Yet
NCT07680244 | RECRUITING | NA
400 participants

(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2025-05-23
Completion:
2026-08-31
Conditions
  • Epiretinal Membrane
  • Dry Age Related Macular Degeneration
  • Macular Abnormalities
  • Retina Disease
  • Vitreoretinal Abnormality
  • Intraretinal Hyporeflective Space
  • Subretinal Hyporeflective Space
  • IS/OS (Ellipsoid Zone) Disruption
  • Retinal Pigment Epithelium (RPE) Elevation
  • Retinal Pigment Epithelium (RPE) Atrophy
Interventions
  • DEVICE
No Results Yet
NCT07632235 | NOT_YET_RECRUITING | PHASE1/PHASE2
112 participants
Previous
Sorted by latest updates
Next
Showing 40 trials per page